| Literature DB >> 15342208 |
Brett T Lund1, Nazely Ashikian, Huy Q Ta, Yervand Chakryan, Krikor Manoukian, Susan Groshen, Wendy Gilmore, Gurtej S Cheema, William Stohl, Margaret E Burnett, David Ko, Norman J Kachuck, Leslie P Weiner.
Abstract
Multiple Sclerosis (MS) is a chronic inflammatory disease of the CNS which is characterized by large mononuclear cell infiltration and significant demyelination. CXCL8 is a chemo-attractant for both neutrophils and monocytes and triggers their firm adhesion to endothelium. In this study, we demonstrate that serum CXCL8 and CXCL8 secretion from PBMCs are significantly higher in untreated MS patients compared to controls and are significantly reduced in MS patients receiving interferon-beta1a therapy. We suggest that CXCL8 may serve as a marker of monocyte activity in MS and may play a role in monocyte recruitment to the CNS. Copyright 2004 Elsevier B.V.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15342208 DOI： 10.1016/j.jneuroim.2004.06.008
Source DB: PubMed Journal: J Neuroimmunol ISSN： 0165-5728 Impact factor: 3.478